Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus

International Journal of Dermatology

Volumn 39, Issue 3, 2000, Pages 218-222

  Kyriakis, Kyriakos P ^a,b   Kontochristopoulos, George J ^a   Panteleos, Demetrius N ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISCOID LUPUS ERYTHEMATOSUS; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; SOMNOLENCE;

ADULT; APPETITE; CONSTIPATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MENSTRUATION DISTURBANCES; MIDDLE AGED; PARESTHESIA; PATIENT DROPOUTS; RECURRENCE; REMISSION INDUCTION; SKIN; SLEEP STAGES; THALIDOMIDE; TREATMENT OUTCOME;

EID: 0034000784     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00953.x     Document Type: Article

References (22)

1. Rowell NR, Goldsmith MJD. The connective tissue diseases. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology. Oxford: Blackwell Scientific Publications, 1992: 2163-2294.
2. Sheskin J, Convit J. Results of double blind study of the influence of thalidomide on the lepra reaction. Int J Lepr Other Mycobact Dis 1969; 37: 135-146.
3. Knop J, Bonsman G, Happle R, et al. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol 1983; 108: 461-466.
4. Naafs B, Bakkers EJM, Flinterman J, Faber WR. Thalidomide treatment of subacute cutaneous lupus erythematosus. Br J Dermatol 1982; 107: 83-86.
5. Atra E, Sato EI. Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide. Clin Exp Rheumatol 1993; 11: 487-493.
6. Londono F. Thalidomide in the treatment of prurigo actinico. Int J Dermatol 1973; 12: 326-328.
7. Revuz J, Guillaume JC, Janier M, et al. Crossover study of thalidomide vs. placebo in severe recurrent aphthous stomatitis. Arch Dermatol 1990; 126: 923-927.
8. van den Brock H. Treatment of prurigo nodularis with thalidomide. Arch Dermatol 1980; 16: 571-572.
9. Bahmer FA, Zaun H, Luszpinski P. Thalidomide in the treatment of recurrent erythema multiforme. Acta Dermatol Venereol (Stockh) 1982; 62: 449-450.
10. Thomas L, Ducros B, Secchi T, et al. Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Arch Dermatol 1993; 129: 1261-1264.
11. Makonkawkeyoon S, Limson-Pobre RNR, Moreira AL, et al. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993; 90: 5974-5978.
12. Moreira AL, Sampaio EP, Zmuidzinas A, et al. Thalidomide exerts its inhibitory action on tumor necrosis factor a by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-1680.
13. Wakefield PE, James WD, Samlaska CP, Meltzer MS. Tumor necrosis factor. J Am Acad Dermatol 1991; 24: 675-685.
14. Sampaio EP, Kaplan G, Miranda A, et al. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis 1993; 168: 408-414.
15. Mchugh SM, Rifkin IR, Deighton J, et al. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 production in mitogen-and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995; 99: 160-167.
16. Kohchiyama A, Oka D, Ueki H. T cell subsets in lesions of systemic and discoid lupus erythematosus. J Cutan Pathol 1985; 12: 493-499.
17. Faure M, Thivolet J, Gaucherand M. Inhibition of PMN leukocytes chemotaxis by thalidomide. Arch Dermatol Res 1980; 269: 275-280.
18. Guillaume JC, Moulin G, Thierno Dieng M, et al. Crossover study of thalidomide vs placebo in Jessner's lymphocytic infiltration of the skin. Arch Dermatol 1995; 131: 1032-1035.
19. Aronson IK, Yu R, West DP, et al. Thalidomide induced peripheral neuropathy. Arch Dermatol 1984; 120: 1466-1470.
20. Revuz J. Actualite du thalidomide. Ann Dermatol Venereol 1990; 117: 313-321.
21. Ochonisky S, Verroust J, Bastuji GS, et al. Thalidomide neuropathy and clinico-electrophysiologic findings in 42 patients. Arch Dermatol 1994; 130: 66-69.
22. Cole CH, Rogers PC, Prichard S, et al. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 937-942.